501 related articles for article (PubMed ID: 28117274)
1. Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1.
Wu J; Jia J; Liu L; Yang F; Fan Y; Zhang S; Yan D; Bu R; Li G; Gao Y; Chen Y
J Am Soc Hypertens; 2017 Mar; 11(3):148-157.e1. PubMed ID: 28117274
[TBL] [Abstract][Full Text] [Related]
2. CTRP9 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and migration via TGF-β1/ERK1/2 signaling pathway.
Li YX; Run L; Shi T; Zhang YJ
Biochem Biophys Res Commun; 2017 Sep; 490(4):1319-1325. PubMed ID: 28688765
[TBL] [Abstract][Full Text] [Related]
3. Schisandrin B inhibits TGF-β1-induced epithelial-mesenchymal transition in human A549 cells through epigenetic silencing of ZEB1.
Zhuang W; Li Z; Dong X; Zhao N; Liu Y; Wang C; Chen J
Exp Lung Res; 2019; 45(5-6):157-166. PubMed ID: 31268360
[No Abstract] [Full Text] [Related]
4. Transforming growth factor-beta1 upregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PTEN/AKT pathways.
Liu Y; Cao Y; Sun S; Zhu J; Gao S; Pang J; Zhu D; Sun Z
Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):141-154. PubMed ID: 27297622
[TBL] [Abstract][Full Text] [Related]
5. The potential of asiaticoside for TGF-β1/Smad signaling inhibition in prevention and progression of hypoxia-induced pulmonary hypertension.
Wang XB; Wang W; Zhu XC; Ye WJ; Cai H; Wu PL; Huang XY; Wang LX
Life Sci; 2015 Sep; 137():56-64. PubMed ID: 26209140
[TBL] [Abstract][Full Text] [Related]
6. Schisandrin B suppresses TGFβ1-induced stress fiber formation by inhibiting myosin light chain phosphorylation.
Chun JN; Kim SY; Park EJ; Kwon EJ; Bae DJ; Kim IS; Kim HK; Park JK; Lee SW; Park HH; So I; Jeon JH
J Ethnopharmacol; 2014 Mar; 152(2):364-71. PubMed ID: 24486209
[TBL] [Abstract][Full Text] [Related]
7. Anti-apoptosis endothelial cell-secreted microRNA-195-5p promotes pulmonary arterial smooth muscle cell proliferation and migration in pulmonary arterial hypertension.
Zeng Z; Yao J; Li Y; Xue Y; Zou Y; Shu Z; Jiao Z
J Cell Biochem; 2018 Feb; 119(2):2144-2155. PubMed ID: 28862358
[TBL] [Abstract][Full Text] [Related]
8. Hypercapnia downregulates hypoxia-induced lysyl oxidase expression in pulmonary artery smooth muscle cells via inhibiting transforming growth factor β
Xia XD; Peng YP; Lei D; Chen WQ
Cell Biochem Funct; 2019 Apr; 37(3):193-202. PubMed ID: 30917408
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of caveolin-1 by DJ-1 attenuates rat pulmonary arterial hypertension by inhibiting TGFβ/Smad signaling pathway.
Gao W; Shao R; Zhang X; Liu D; Liu Y; Fa X
Exp Cell Res; 2017 Dec; 361(1):192-198. PubMed ID: 29069575
[TBL] [Abstract][Full Text] [Related]
11. Calpain-2 activates Akt via TGF-β1-mTORC2 pathway in pulmonary artery smooth muscle cells.
Abeyrathna P; Kovacs L; Han W; Su Y
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C24-34. PubMed ID: 27099352
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-β1/smad2/3 signaling.
Li P; Song J; Du H; Lu Y; Dong S; Zhou S; Guo Z; Wu H; Zhao X; Qin Y; Zhu N
J Mol Cell Cardiol; 2021 Dec; 161():9-22. PubMed ID: 34339758
[TBL] [Abstract][Full Text] [Related]
13. [Effect of schisandrin B on lung mRNA expression of transforming growth factor-beta1 signal transduction molecule in rat lungs exposed to silica].
Fan LH; Liu TF; Guo M; Liu ML; Wang ZP; Si SJ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Apr; 29(4):255-9. PubMed ID: 21941776
[TBL] [Abstract][Full Text] [Related]
14. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4.
Zhang D; Liu B; Cao B; Wei F; Yu X; Li GF; Chen H; Wei LQ; Wang PL
Int Immunopharmacol; 2017 Jul; 48():67-75. PubMed ID: 28476015
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1.
Yu L; Tu Y; Jia X; Fang K; Liu L; Wan L; Xiang C; Wang Y; Sun X; Liu T; Yu D; Cao W; Song Y; Fan Y
Cell Physiol Biochem; 2017; 42(1):55-67. PubMed ID: 28494457
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
Kouri FM; Queisser MA; Königshoff M; Chrobak I; Preissner KT; Seeger W; Eickelberg O
Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154
[TBL] [Abstract][Full Text] [Related]
17. Fluorofenidone attenuates vascular remodeling in hypoxia-induced pulmonary hypertension of rats.
Li XW; Du J; Hu GY; Hu CP; Li D; Li YJ; Li XH
Can J Physiol Pharmacol; 2014 Jan; 92(1):58-69. PubMed ID: 24383874
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl
Zhang H; Chen Q; Dahan A; Xue J; Wei L; Tan W; Zhang G
Chem Biol Interact; 2019 Aug; 309():108675. PubMed ID: 31150632
[TBL] [Abstract][Full Text] [Related]
19. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway.
Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]